ROBERT HIEGER: Open Payments
NPI 1801328612 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,203 in 68 payments from 19 companies in 2025. Trend: 2023 $1,351 · 2024 $2,014 · 2025 $1,203
Food & beverage: $1,203
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $365 |
| PFIZER INC. | 11 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Sumitomo Pharma America, Inc. | 3 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Exact Sciences Corporation | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $55 |
| Novo Nordisk Inc | 3 | $50 |
| Medtronic, Inc. | 2 | $40 |
| Amgen Inc. | 2 | $37 |
Products named: QULIPTA, VRAYLAR, NURTEC ODT, CAPLYTA, GEMTESA, XIFAXAN, UBRELVY, Cologuard Collection Kit.
Industry payments across MO — which companies pay providers there.
